SCHEMBL8986955

SCHEMBL8986955

Cc1ccc(-c2cc(=O)[nH]c3ccccc23)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.74
SMN1; SMN2 Q16637 3/20 0.74
MAPK1 P28482 1/20 0.74
HTT P42858 1/20 0.74
TNKS2 Q9H2K2 3/20 0.62
CYP1A2 P05177 2/20 0.62
CYP2C19 P33261 1/20 0.62
CTSV O60911 1/20 0.59
CTSL P07711 1/20 0.59
RAB9A P51151 1/20 0.59
KMT2A Q03164 3/20 0.54
KDM4E B2RXH2 4/20 0.51
MEN1 O00255 2/20 0.51
ALDH1A1 P00352 2/20 0.51
NPC1 O15118 1/20 0.51
POLB P06746 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51
BRD4 O60885 2/20 0.49
ADORA3 P0DMS8 1/20 0.49
PDE9A O76083 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12871194 0.86 HPGD (0.69) HPGDSMN1; SMN2MAPK1HTTTNKS2
SCHEMBL29612166 0.85 HPGD (1.00) HPGDSMN1; SMN2MAPK1HTTTNKS2
SCHEMBL1173520 0.85 HPGD (1.00) HPGDSMN1; SMN2MAPK1HTTTNKS2
SCHEMBL28133652 0.85 HPGD (1.00) HPGDSMN1; SMN2MAPK1HTTTNKS2
SCHEMBL8987096 0.83 HPGD (0.70) HPGDSMN1; SMN2MAPK1HTTTNKS2
SCHEMBL8987418 0.83 HPGD (0.74) HPGDSMN1; SMN2MAPK1HTTTNKS2
SCHEMBL8987046 0.83 HPGD (0.74) HPGDSMN1; SMN2MAPK1HTTTNKS2
SCHEMBL8987263 0.82 HPGD (0.68) HPGDSMN1; SMN2MAPK1HTTTNKS2
SCHEMBL8986966 0.82 KDM4E (0.71) HPGDSMN1; SMN2MAPK1HTTTNKS2
SCHEMBL31677372 0.82 KDM4E (0.71) HPGDSMN1; SMN2MAPK1HTTTNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106432074-B A method of 4- aryl -2- quinolinone is prepared by carbon dioxide 常州大学 2019-01-29 CN disclosed
CN-106432074-A Method for preparing 4-aryl-2-quinolinone through carbon dioxide 常州大学 2017-02-22 CN disclosed
US-5492915-A ANTIINFLAMMATORY AGENTS RHONE-POULENC RORER S.A. (FR) 1996-02-20 US disclosed
US-5366982-A Antiinflammatory agents or antihistamines RHONE-POULENC RORER S.A. (FR) 1994-11-22 US disclosed
EP-0540604-A1 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS Aventis Pharma S.A. (FR) 1993-05-12 EP disclosed
WO-1992001675-A2 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS RHONE-POULENC RORER S.A. (FR) 1992-02-06 WO disclosed
US-4758566-A 2-(1-piperazinyl)-4-substituted phenylquinoline derivatives, processes for the preparation thereof, and pharmaceutical composition containing the same DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1988-07-19 US disclosed
EP-0204003-A1 2-(1-PIPERAZINYL)-4-SUBSTITUTED PHENYLQUINOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICINAL COMPOSITION CONTAINING SAME Dainippon Pharmaceutical Co., Ltd. (JP) 1986-12-10 EP disclosed